A multi center randomised cross over double blind third party open placebo controlled pilot study to assess the urodynamic effects of modified release UK-369,003 in men with lower urinary tract symptoms

Trial Profile

A multi center randomised cross over double blind third party open placebo controlled pilot study to assess the urodynamic effects of modified release UK-369,003 in men with lower urinary tract symptoms

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Gisadenafil (Primary)
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Sep 2008 Actual patient number (27) added as reported by ClinicalTrials.gov.
    • 03 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top